Wallenberg Neuroscience Centre, Lund
41 – 50 of 195
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Are Stem Cell-Based Therapies for Parkinson's Disease Ready for the Clinic in 2016?
(
- Contribution to journal › Article
-
Mark
Comparability : Manufacturing, characterization and controls, report of a UK Regenerative Medicine Platform Pluripotent Stem Cell Platform Workshop, Trinity Hall, Cambridge, 14-15 September 2015
(
- Contribution to journal › Article
-
Mark
L23 Effects of peripheral (co-)administration of liraglutide and ghrelin in the R6/2 mouse brain function
2016) European Huntington Disease Network conference 2016 In Journal of Neurology, Neurosurgery and Psychiatry 87(Suppl 1). p.98-98(
- Contribution to journal › Published meeting abstract
-
Mark
L24 The effect of ghrelin administration in the R6/2 mouse model of Huntington’s disease
2016) European Huntington Disease Network conference 2016 In Journal of Neurology, Neurosurgery and Psychiatry 87(Suppl 1).(
- Contribution to journal › Published meeting abstract
- 2015
-
Mark
Cyclosporin promotes neurorestoration and cell replacement therapy in pre-clinical models of Parkinson's disease.
(
- Contribution to journal › Article
- 2014
-
Mark
A compact multifunctional microfluidic platform for exploring cellular dynamics in real-time using electrochemical detection
(
- Contribution to journal › Article
-
Mark
Gene Therapy for Parkinson’s Disease
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Long-term clinical outcome of fetal cell transplantation for Parkinson disease : two case reports
(
- Contribution to journal › Article
- 2013
-
Mark
Regulation of stem cell therapies under attack in Europe: for whom the bell tolls
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Proposal for a "phase II" multicenter trial model for preclinical new antiepilepsy therapy development
(
- Contribution to journal › Article